U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C5H8NO4.Fe
Molecular Weight 348.0882
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS GLUTAMATE

SMILES

C(CC(=O)O)[C@@]([H])(C(=O)O)N.C(CC(=O)[O-])[C@@]([H])(C(=O)[O-])N.[Fe+2]

InChI

InChIKey=XXDVUVPHJGZWQC-QHTZZOMLSA-L
InChI=1S/2C5H9NO4.Fe/c2*6-3(5(9)10)1-2-4(7)8;/h2*3H,1-2,6H2,(H,7,8)(H,9,10);/q;;+2/p-2/t2*3-;/m00./s1

HIDE SMILES / InChI

Molecular Formula C5H8NO4
Molecular Weight 146.1215
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Fe
Molecular Weight 55.8451
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

FERROUS ASPARTATE is an iron supplement used to treat or prevent low blood levels of iron. Iron is an important mineral that the body needs to produce red blood cells and keep you in good health.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Unknown

Approved Use

Unknown
Palliative
Unknown

Approved Use

Unknown
Primary
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Curative
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

1.06496642E12
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS.
1932 Jul 1
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
THE ADMINISTRATION OF FERROUS IODIDE AND LINOLEIC ACID TO RATS DEPRIVED OF VITAMIN A.
1932 Sep 30
THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA.
1937 Jul
[Ferrous lactate as an oral iron preparation for therapeutic use].
1954 Nov 27
Clinical appraisal of drugs with special reference to a new chelate hematinic.
1957 Jul 11
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
[Historical notes on the therapy of depression].
1986 Nov 22
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe.
1997 Oct
Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
2007
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.
2009
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study.
2009 Nov 15
The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia.
2010 Dec
Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis.
2011 Jun 10
Tolerability of different oral iron supplements: a systematic review.
2013 Apr
Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows.
2013 Jul
A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts.
2014
Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes.
2015 Jun 22
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.
2017 Jul 5
Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes.
2017 Mar 13
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.
2017 May 1
Patents

Sample Use Guides

as food additives
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Jun 25 23:50:04 UTC 2021
Edited
by admin
on Fri Jun 25 23:50:04 UTC 2021
Record UNII
NK5255J7U8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS GLUTAMATE
WHO-DD  
Common Name English
L-GLUTAMIC ACID, IRON COMPLEX
Common Name English
IRON, BIS(HYDROGEN GLUTAMATO)-
Common Name English
FERRATE(2-), BIS(L-GLUTAMATO(1-)-.KAPPA.N,.KAPPA.O1)-, HYDROGEN (1:2), (T-4)-
Common Name English
FERROUS GLUTAMATE [WHO-DD]
Common Name English
IRON(II) DIGLUTAMATE
Systematic Name English
L-GLUTAMIC ACID, IRON(2+) SALT
Common Name English
Code System Code Type Description
FDA UNII
NK5255J7U8
Created by admin on Fri Jun 25 23:50:04 UTC 2021 , Edited by admin on Fri Jun 25 23:50:04 UTC 2021
PRIMARY
EPA CompTox
12170-54-6
Created by admin on Fri Jun 25 23:50:04 UTC 2021 , Edited by admin on Fri Jun 25 23:50:04 UTC 2021
PRIMARY
CAS
12170-54-6
Created by admin on Fri Jun 25 23:50:04 UTC 2021 , Edited by admin on Fri Jun 25 23:50:04 UTC 2021
PRIMARY
EVMPD
SUB13868MIG
Created by admin on Fri Jun 25 23:50:04 UTC 2021 , Edited by admin on Fri Jun 25 23:50:04 UTC 2021
PRIMARY
PUBCHEM
71586949
Created by admin on Fri Jun 25 23:50:04 UTC 2021 , Edited by admin on Fri Jun 25 23:50:04 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY